The overexpression of HER2, primarily due to gene amplification, occurs in approximately 25–30% of invasive human BCs [93] and its downstream signaling pathway is responsible for several features of BC cells, i.e., cell proliferation and migration, resistance to apoptosis, activation of the angiogenic cascade, and the metastatic process [94]. The gene discussed is ERBB2; the disease is breast cancer.